EA200400716A1 - 3-(имидазолил)-2-алкоксипропионовые кислоты в качестве ингибиторов tafia (тромбин-активируемого ингибитора фибринолиза) - Google Patents

3-(имидазолил)-2-алкоксипропионовые кислоты в качестве ингибиторов tafia (тромбин-активируемого ингибитора фибринолиза)

Info

Publication number
EA200400716A1
EA200400716A1 EA200400716A EA200400716A EA200400716A1 EA 200400716 A1 EA200400716 A1 EA 200400716A1 EA 200400716 A EA200400716 A EA 200400716A EA 200400716 A EA200400716 A EA 200400716A EA 200400716 A1 EA200400716 A1 EA 200400716A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alcoxypropionic
thrombin
imidazolyl
acids
fibrinolysis inhibitor
Prior art date
Application number
EA200400716A
Other languages
English (en)
Russian (ru)
Inventor
Шарлотт Мойра Норфор Аллертон
Дейвид Джон Булл
Марк Эдвард Баннэйдж
Роберт Джон Магайр
Джон Стил
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201389A external-priority patent/GB0201389D0/en
Priority claimed from GB0202027A external-priority patent/GB0202027D0/en
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of EA200400716A1 publication Critical patent/EA200400716A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200400716A 2002-01-22 2003-01-10 3-(имидазолил)-2-алкоксипропионовые кислоты в качестве ингибиторов tafia (тромбин-активируемого ингибитора фибринолиза) EA200400716A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0201389A GB0201389D0 (en) 2002-01-22 2002-01-22 3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en) 2002-01-29 2002-01-29 3-(imidazolyl)-2-alkoxypropanoic acids
PCT/IB2003/000060 WO2003061652A1 (en) 2002-01-22 2003-01-10 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors

Publications (1)

Publication Number Publication Date
EA200400716A1 true EA200400716A1 (ru) 2004-12-30

Family

ID=27614792

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400716A EA200400716A1 (ru) 2002-01-22 2003-01-10 3-(имидазолил)-2-алкоксипропионовые кислоты в качестве ингибиторов tafia (тромбин-активируемого ингибитора фибринолиза)

Country Status (24)

Country Link
EP (1) EP1467731A1 (zh)
JP (1) JP2005520811A (zh)
KR (1) KR20040077775A (zh)
CN (1) CN1620291A (zh)
AP (1) AP2004003084A0 (zh)
AR (1) AR038197A1 (zh)
BR (1) BR0307016A (zh)
CA (1) CA2472238A1 (zh)
EA (1) EA200400716A1 (zh)
EC (1) ECSP045200A (zh)
HR (1) HRP20040659A2 (zh)
IL (1) IL162677A0 (zh)
IS (1) IS7310A (zh)
MA (1) MA27167A1 (zh)
MX (1) MXPA04006573A (zh)
NO (1) NO20043457L (zh)
OA (1) OA12756A (zh)
PA (1) PA8563501A1 (zh)
PE (1) PE20030929A1 (zh)
PL (1) PL371487A1 (zh)
TN (1) TNSN04121A1 (zh)
TW (1) TW200302094A (zh)
UY (1) UY27615A1 (zh)
WO (1) WO2003061652A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051384A1 (en) * 2003-11-25 2005-06-09 Pfizer Limited Stabilised pharmaceutical compositions
WO2006113247A1 (en) * 2005-04-18 2006-10-26 Bayer Schering Pharma Aktiengesellschaft Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci
CA2741783A1 (en) 2008-10-29 2010-05-06 Taisho Pharmaceutical Co., Ltd. Compounds having tafia inhibitory activity
TW201033184A (en) * 2008-12-05 2010-09-16 Mochida Pharm Co Ltd Morpholinone compounds as factor IXa inhibitors
US8987242B2 (en) 2008-12-05 2015-03-24 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXA inhibitors
CN105801489B (zh) * 2010-03-18 2019-12-10 第一三共株式会社 环烷基取代的咪唑衍生物
JP5778133B2 (ja) * 2010-03-18 2015-09-16 第一三共株式会社 シクロプロパンカルボン酸誘導体
AU2014280329A1 (en) 2013-06-10 2016-01-07 Sanofi Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals
KR20180123038A (ko) 2016-03-29 2018-11-14 다이이찌 산쿄 가부시키가이샤 염증성 장질환 치료제
JP7158393B2 (ja) 2017-09-14 2022-10-21 第一三共株式会社 環状構造を有する化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
WO2002014285A1 (en) * 2000-08-17 2002-02-21 Pfizer Limited Substituted imidazoles as tafia inhibitors

Also Published As

Publication number Publication date
IL162677A0 (en) 2005-11-20
PA8563501A1 (es) 2004-08-31
PE20030929A1 (es) 2003-11-05
NO20043457L (no) 2004-08-19
JP2005520811A (ja) 2005-07-14
MA27167A1 (fr) 2005-01-03
MXPA04006573A (es) 2004-10-04
AP2004003084A0 (en) 2004-09-30
ECSP045200A (es) 2004-08-27
OA12756A (en) 2006-07-03
KR20040077775A (ko) 2004-09-06
WO2003061652A1 (en) 2003-07-31
BR0307016A (pt) 2004-11-03
AR038197A1 (es) 2005-01-05
IS7310A (is) 2004-06-14
EP1467731A1 (en) 2004-10-20
CA2472238A1 (en) 2003-07-31
WO2003061652A8 (en) 2004-09-10
UY27615A1 (es) 2003-08-29
TNSN04121A1 (en) 2006-06-01
CN1620291A (zh) 2005-05-25
PL371487A1 (en) 2005-06-13
TW200302094A (en) 2003-08-01
HRP20040659A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
EA200600358A1 (ru) Фенил- или пиридиламидные соединения в качестве антагонистов простагландина е2
EA200600509A1 (ru) Соединения пиримидотиофена
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
EA200200253A1 (ru) Ингибиторы клеточной адгезии
DE60332856D1 (de) Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
CY1108409T1 (el) Υβριδικα αντιβιοτικα οξαζολιδινονης-κινολονης
EP1052254A4 (en) NITROGENIC HETEROCYCLIC DERIVATIVES AND DRUGS PRODUCED FROM SUCH DERIVATIVES
EA200400716A1 (ru) 3-(имидазолил)-2-алкоксипропионовые кислоты в качестве ингибиторов tafia (тромбин-активируемого ингибитора фибринолиза)
ATE442139T1 (de) 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы
BR0313969A (pt) Inibidores de oxitocina
EA200701866A1 (ru) Стабилизирующая композиция для галогенидсодержащих полимеров
DE60128731D1 (de) Tripeptidylpeptidase-hemmer
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
ATE235462T1 (de) Metalloproteinase-inhibitoren
MXPA04005940A (es) Acidos 3-(imidazolil)-2-aminopropanoicos.
NO970340L (no) Organiske forbindelser
ATE539756T1 (de) Prostaglandinsubstanzen für die behandlung von fettsucht
ATE449773T1 (de) Homomorpholinoxazolidinone als antibakterielle mittel
DE60124717D1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
EA199901006A1 (ru) Фунгицидная смесь
BR0317719A (pt) Derivados de fosforamida
EA200101103A1 (ru) НОВЫЕ 15-ЧЛЕННЫЕ 8а- И 9а ЛАКТАМЫ
EA200601106A1 (ru) Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции